WO2005009219A2 - Method for making a spiral array ultrasound transducer - Google Patents
Method for making a spiral array ultrasound transducer Download PDFInfo
- Publication number
- WO2005009219A2 WO2005009219A2 PCT/US2004/023332 US2004023332W WO2005009219A2 WO 2005009219 A2 WO2005009219 A2 WO 2005009219A2 US 2004023332 W US2004023332 W US 2004023332W WO 2005009219 A2 WO2005009219 A2 WO 2005009219A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- transducer
- ceramic tube
- ablation
- helical
- coating
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 98
- 238000002604 ultrasonography Methods 0.000 title claims description 18
- 239000000463 material Substances 0.000 claims abstract description 42
- 239000000919 ceramic Substances 0.000 claims description 31
- 229910010293 ceramic material Inorganic materials 0.000 claims description 21
- 230000008569 process Effects 0.000 claims description 16
- 238000000576 coating method Methods 0.000 claims description 14
- 238000003754 machining Methods 0.000 claims description 14
- 239000011248 coating agent Substances 0.000 claims description 13
- 229910052751 metal Inorganic materials 0.000 claims description 11
- 239000002184 metal Substances 0.000 claims description 11
- 239000013078 crystal Substances 0.000 claims description 9
- 238000004544 sputter deposition Methods 0.000 claims description 7
- 238000005530 etching Methods 0.000 claims description 6
- 229920000642 polymer Polymers 0.000 claims description 6
- 230000005684 electric field Effects 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000010329 laser etching Methods 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 230000001131 transforming effect Effects 0.000 claims description 4
- 238000007747 plating Methods 0.000 claims description 3
- 238000009987 spinning Methods 0.000 claims description 3
- 241000507649 Kerria japonica Species 0.000 claims description 2
- 239000003082 abrasive agent Substances 0.000 claims description 2
- 238000005229 chemical vapour deposition Methods 0.000 claims description 2
- 238000003618 dip coating Methods 0.000 claims description 2
- 238000007765 extrusion coating Methods 0.000 claims description 2
- 238000010030 laminating Methods 0.000 claims description 2
- 238000000465 moulding Methods 0.000 claims description 2
- 238000004528 spin coating Methods 0.000 claims description 2
- 238000005507 spraying Methods 0.000 claims description 2
- 238000005553 drilling Methods 0.000 claims 2
- 238000005498 polishing Methods 0.000 claims 2
- 238000002679 ablation Methods 0.000 abstract description 104
- 210000001519 tissue Anatomy 0.000 description 59
- 210000003492 pulmonary vein Anatomy 0.000 description 49
- 230000001746 atrial effect Effects 0.000 description 29
- 238000010276 construction Methods 0.000 description 19
- 206010003658 Atrial Fibrillation Diseases 0.000 description 17
- 230000003902 lesion Effects 0.000 description 17
- 238000000429 assembly Methods 0.000 description 16
- 230000000712 assembly Effects 0.000 description 16
- 239000012530 fluid Substances 0.000 description 13
- 206010003119 arrhythmia Diseases 0.000 description 12
- 210000005246 left atrium Anatomy 0.000 description 11
- 230000002159 abnormal effect Effects 0.000 description 10
- 238000013461 design Methods 0.000 description 10
- 229910052737 gold Inorganic materials 0.000 description 10
- 206010003130 Arrhythmia supraventricular Diseases 0.000 description 9
- 230000003126 arrythmogenic effect Effects 0.000 description 9
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 9
- 239000010931 gold Substances 0.000 description 9
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 8
- 210000002837 heart atrium Anatomy 0.000 description 8
- 210000005003 heart tissue Anatomy 0.000 description 8
- 238000012544 monitoring process Methods 0.000 description 7
- 238000013459 approach Methods 0.000 description 6
- 230000006793 arrhythmia Effects 0.000 description 6
- 210000005242 cardiac chamber Anatomy 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 6
- 230000010363 phase shift Effects 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- 238000004873 anchoring Methods 0.000 description 4
- 230000000747 cardiac effect Effects 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 230000001186 cumulative effect Effects 0.000 description 4
- 229910052759 nickel Inorganic materials 0.000 description 4
- 230000037361 pathway Effects 0.000 description 4
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 3
- 208000005189 Embolism Diseases 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- 238000013153 catheter ablation Methods 0.000 description 3
- 230000001427 coherent effect Effects 0.000 description 3
- 210000003748 coronary sinus Anatomy 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000002332 fibrillatory effect Effects 0.000 description 3
- 230000001788 irregular Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000003252 repetitive effect Effects 0.000 description 3
- 230000011218 segmentation Effects 0.000 description 3
- 238000005476 soldering Methods 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 241000282465 Canis Species 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 230000001594 aberrant effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000013130 cardiovascular surgery Methods 0.000 description 2
- 239000004020 conductor Substances 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000007831 electrophysiology Effects 0.000 description 2
- 238000002001 electrophysiology Methods 0.000 description 2
- 230000002357 endometrial effect Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000000004 hemodynamic effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 210000000115 thoracic cavity Anatomy 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 201000009273 Endometriosis Diseases 0.000 description 1
- -1 Gold ions Chemical class 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000011682 Mitral valve disease Diseases 0.000 description 1
- 206010050106 Paroxysmal arrhythmia Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 208000001435 Thromboembolism Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004375 bundle of his Anatomy 0.000 description 1
- 206010061592 cardiac fibrillation Diseases 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 238000010292 electrical insulation Methods 0.000 description 1
- 229920006332 epoxy adhesive Polymers 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000002600 fibrillogenic effect Effects 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 210000004115 mitral valve Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000000135 prohibitive effect Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 238000007674 radiofrequency ablation Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 210000001013 sinoatrial node Anatomy 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000013077 target material Substances 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B06—GENERATING OR TRANSMITTING MECHANICAL VIBRATIONS IN GENERAL
- B06B—METHODS OR APPARATUS FOR GENERATING OR TRANSMITTING MECHANICAL VIBRATIONS OF INFRASONIC, SONIC, OR ULTRASONIC FREQUENCY, e.g. FOR PERFORMING MECHANICAL WORK IN GENERAL
- B06B1/00—Methods or apparatus for generating mechanical vibrations of infrasonic, sonic, or ultrasonic frequency
- B06B1/02—Methods or apparatus for generating mechanical vibrations of infrasonic, sonic, or ultrasonic frequency making use of electrical energy
- B06B1/06—Methods or apparatus for generating mechanical vibrations of infrasonic, sonic, or ultrasonic frequency making use of electrical energy operating with piezoelectric effect or with electrostriction
- B06B1/0607—Methods or apparatus for generating mechanical vibrations of infrasonic, sonic, or ultrasonic frequency making use of electrical energy operating with piezoelectric effect or with electrostriction using multiple elements
- B06B1/0622—Methods or apparatus for generating mechanical vibrations of infrasonic, sonic, or ultrasonic frequency making use of electrical energy operating with piezoelectric effect or with electrostriction using multiple elements on one surface
- B06B1/0633—Cylindrical array
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/22004—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
- A61B17/22012—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement
- A61B17/2202—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement the ultrasound transducer being inside patient's body at the distal end of the catheter
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04R—LOUDSPEAKERS, MICROPHONES, GRAMOPHONE PICK-UPS OR LIKE ACOUSTIC ELECTROMECHANICAL TRANSDUCERS; DEAF-AID SETS; PUBLIC ADDRESS SYSTEMS
- H04R31/00—Apparatus or processes specially adapted for the manufacture of transducers or diaphragms therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N7/02—Localised ultrasound hyperthermia
- A61N7/022—Localised ultrasound hyperthermia intracavitary
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04R—LOUDSPEAKERS, MICROPHONES, GRAMOPHONE PICK-UPS OR LIKE ACOUSTIC ELECTROMECHANICAL TRANSDUCERS; DEAF-AID SETS; PUBLIC ADDRESS SYSTEMS
- H04R17/00—Piezoelectric transducers; Electrostrictive transducers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10N—ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10N30/00—Piezoelectric or electrostrictive devices
- H10N30/01—Manufacture or treatment
- H10N30/08—Shaping or machining of piezoelectric or electrostrictive bodies
- H10N30/085—Shaping or machining of piezoelectric or electrostrictive bodies by machining
- H10N30/086—Shaping or machining of piezoelectric or electrostrictive bodies by machining by polishing or grinding
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/42—Piezoelectric device making
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49002—Electrical device making
- Y10T29/49117—Conductor or circuit manufacturing
- Y10T29/49124—On flat or curved insulated base, e.g., printed circuit, etc.
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49002—Electrical device making
- Y10T29/49117—Conductor or circuit manufacturing
- Y10T29/49124—On flat or curved insulated base, e.g., printed circuit, etc.
- Y10T29/49155—Manufacturing circuit on or in base
- Y10T29/49156—Manufacturing circuit on or in base with selective destruction of conductive paths
Definitions
- the present invention relates to a method for making a surgical device. More particularly, it relates to a method for making a tissue ablation transducer having a plurality of helical elements that can be operated out of phase to orient the acoustical energy beam forward or backward in the longitudinal direction.
- cardiac arrhythmia abnormal regions of cardiac tissue do not follow the synchronous beating cycle associated with normally conductive tissue in patients with sinus rhythm. Instead, the abnormal regions of cardiac tissue aberrantly conduct to adjacent tissue, thereby disrupting the cardiac cycle into an asynchronous cardiac rhythm.
- Cardiac arrhytlimias including atrial arrhythmia, may be of a multiwavelet reentrant type, characterized by multiple asynchronous loops of electrical impulses that are scattered about the atrial chamber and are often self-propagating.
- cardiac arrhythmias may also have a focal origin, such as when an isolated region of tissue in an atrium fires autonomously in a rapid, repetitive fashion.
- Cardiac arrhythmias, including atrial fibrillation may be generally detected using the global technique of an electrocardiogram (EKG). More sensitive procedures of mapping the specific conduction along the cardiac chambers have also been disclosed, such as, for example, in U.S. Pat. No. 4,641,649 to Walinsky et al. and in PCT Patent Application Publication No. WO 96/32897 to Desai.
- a host of clinical conditions can result from the irregular cardiac function and resulting hemodynamic abnormalities associated with atrial fibrillation, including stroke, heart failure, and other thromboembolic events.
- atrial fibrillation is believed to be a significant cause of cerebral stroke, wherein the abnormal hemodynamics in the left atrium caused by the fibrillatory wall motion precipitate the formation of thrombus within the atrial chamber.
- a thromboembolism is ultimately dislodged into the left ventricle that thereafter pumps the embolism into the cerebral circulation where a stroke results.
- numerous procedures for treating atrial arrhythmias have been developed, including pharmacological, surgical, and catheter ablation procedures.
- the "maze procedure” procedure is designed to relieve atrial arrhythmia by restoring effective atrial systole and sinus node control through a prescribed pattern of incisions about the tissue wall.
- the "maze" procedure included surgical incisions in both the right and the left atrial chambers.
- the "maze procedure” as performed in the left atrium generally includes forming vertical incisions from the two superior pulmonary veins and terminating in the region of the mitral valve annulus, traversing the region of the inferior pulmonary veins en route. An additional horizontal line also connects the superior ends of the two vertical incisions.
- the atrial wall region bordered by the pulmonary vein ostia is isolated from the other atrial tissue.
- the mechanical sectioning of atrial tissue eliminates the arrhythmogenic conduction from the boxed region of the pulmonary veins to the rest of the atrium by creating conduction blocks within the aberrant electrical conduction pathways.
- Other variations or modifications of this specific pattern just described have also been disclosed, all sharing the primary purpose of isolating known or suspected regions of arrhythmogenic origin or propagation along the atrial wall. While the "maze" procedure and its variations as reported by Dr. Cox and others have met some success in treating patients with atrial arrhythmia, its highly invasive methodology is believed to be prohibitive in most cases.
- tissue ablation device assemblies have been recently developed for the specific purpose of ensuring firm contact and consistent positioning of a linear ablation element along a length of tissue by anchoring the element at least at one predetermined location along that length, such as in order to form a "maze"-type lesion pattern in the left atrium.
- One example of such assemblies is that disclosed in U.S. Pat. No. 5,971,983, issued Oct. 26, 1999, which is hereby incorporated by reference.
- the assembly includes an anchor at each of two ends of a linear ablation element in order to secure those ends to each of two predetermined locations along a left atrial wall, such as at two adjacent pulmonary veins, so that tissue may be ablated along the length of tissue extending there between.
- ablation device and method In addition to attempting atrial wall segmentation with long linear lesions for treating atrial arrhythmia, other ablation device and method have also been disclosed which are intended to use expandable members such as balloons to ablate cardiac tissue. Some such devices have been disclosed primarily for use in ablating tissue wall regions along the cardiac chambers. Other devices and methods have been disclosed for treating abnormal conduction of the left-sided accessory pathways, and in particular associated with "Wolff-Parkinson-White" syndrome—various such disclosures use a balloon for ablating from within a region of an associated coronary sinus adjacent to the desired cardiac tissue to ablate.
- Atrial fibrillation Originating from Foci in Pulmonary Veins
- Various modes of atrial fibrillation have also been observed to be focal in nature, caused by the rapid and repetitive firing of an isolated center within cardiac muscle tissue associated with the atrium. Such foci may act as either a trigger of atrial fibrillatory paroxysmal or may even sustain the fibrillation.
- focal atrial arrhythmia often originates from at least one tissue region along one or more of the pulmonary veins of the left atrium, and even more particularly in the superior pulmonary veins.
- Less-invasive percutaneous catheter ablation techniques have been disclosed which use end-electrode catheter designs with the intention of ablating and thereby treating focal arrhythmias in the pulmonary veins.
- the site of the arrhythmogenic foci were generally located just inside the superior pulmonary vein, and the focal ablations were generally performed using a standard 4 mm tip single ablation electrode.
- Another focal ablation method of treating atrial arrhythmias is disclosed in Jais et al., "A focal source of atrial fibrillation treated by discrete radiofrequency ablation," Circulation 95:572-576 (1997). Jais et al. discloses treating patients with paroxysmal arrhythmias originating from a focal source by ablating that source.
- At the site of arrhythmogenic tissue, in both right and left atria several pulses of a discrete source of radiofrequency energy were applied in order to eliminate the fibrillatory process.
- the present invention relates to a method for making a device assembly and tissue ablation transducer having a plurality of helical elements that can be operated out of phase to orient the acoustical energy beam forward or backward in the longitudinal direction.
- the method for making a piezoelectric transducer comprises first providing a ceramic material blank, and machining the blank into a tubular configuration. The ceramic tube is coated with a metallic layer. The metal coated ceramic tube is then machined to form an inner electrode and a series of helically intertwined outer electrodes, each outer electrode being associated with a transducer segment.
- a method of making a piezoelectric transducer, having a plurality of transducer segment, from a PZT ceramic tube comprises coating the inside and outside of the ceramic tube with a metallic layer. In pertinent part, this step fo ⁇ ns an inner electrode and an outer electrode. At least the outer electrode is then etched to form a plurality of intertwined helical transducer segments.
- a method of making an ultrasound transducer with a helical phased array comprises providing a cylindrical piezoelectric transducer having a piezoelectric material disposed between a cylindrical inner electrode and a cylindrical outer electrode. Grooves are then machined through at least the outer electrode to segment the transducer into a plurality of functionally discrete intertwined helical transducer segments.
- Figure 1A is a perspective representation showing an example of a circular ablation path.
- Figure IB is a perspective representation showing an example of an elliptical ablation path.
- Figure 1C is a perspective representation showing an example of an irregular ablation path.
- Figure ID is a perspective representation showing an example of a stepped ablation path.
- Figure 2A is a perspective view showing an ablation catheter operably connected to an ablation control system and a position sensing system according to one embodiment of the present invention. An expandable member of the catheter is illustrated in an expanded state.
- Figure 2B is a perspective view showing the details of an ablation member in the expanded state at a distal end of the ablation catheter of Figure 2 A according to one embodiment of the present invention.
- Figure 3A is a transverse cross-section view showing the construction of a typical prior art cylindrical ultrasonic transducer having inner and outer electrodes.
- Figure 3B is a perspective view of a typical prior art ultrasound transducer in isolation, showing the electrical leads coupled to the transducer.
- Figure 3C is a perspective view of a prior art ultrasound transducer with individually driven sectors.
- Figure 3D is a side view of a prior art ablation catheter showing the collimated radial acoustical energy beam paths when the ablation device is place in a body lumen, such as a pulmonary vein.
- Figure 3E is a side view of a prior art ablation catheter showing the collimated radial acoustical energy beam paths when the ablation device is placed at the juncture between a body lumen and a body cavity, such as a pulmonary vein ostium.
- Figure 4A is a perspective view showing the construction of a transducer sectioned into a spiral array of ultrasonic transducer segments according to one embodiment of the present invention.
- Figure 4B is a side view showing the construction of a transducer sectioned into a spiral array of ultrasonic transducer segments according to one embodiment of the present invention.
- Figure 4C is an end view showing the construction of a transducer sectioned into a spiral array of ultrasonic transducer segments according to one embodiment of the present invention.
- Figure 5 A is a section view showing the construction of a transducer segmented by intertwined individual helical elements essentially into an array of functionally discrete transducer segments according to one embodiment of the present invention.
- Figure 5B is a close-up section view showing the construction of a transducer segmented by intertwined individual helical elements essentially into an array of functionally discrete transducer segments according to one embodiment of the present invention.
- Figure 6A is a section view showing the construction of a transducer having grooves extending through the outer electrode and into the cylindrical piezoelectric material according to one embodiment of the present invention.
- Figure 6B is a close-up section view showing the construction of a transducer having grooves extending through the outer electrode and into the cylindrical piezoelectric material according to one embodiment of the present invention.
- Figure 7A is a schematic representation illustrating a fixed phase delay for sinusoidal input signals driving an array of transducers segments according to one embodiment of the present invention.
- Figure 7B is a schematic representation illustrating the resultant cumulative acoustic energy beams emanating from each of the plurality of transducer elements when driven at different frequencies according to one embodiment of the present invention.
- Figure 7C is a side view of an ablation catheter showing the acoustical energy beam paths projected at an angle relative to the transducer longitudinal axis when the ablation device is placed at the juncture between a body lumen and a body cavity, such as a pulmonary vein ostium.
- Figure 8 is a flow diagram illustrating the method for making a transducer having a plurality of helical transducer elements according to one embodiment of the present invention.
- body space including derivatives thereof, is herein intended to mean any cavity or lumen within the body that is defined at least in part by a tissue wall.
- tissue wall For example, the cardiac chambers, the uterus, the regions of the gastrointestinal tract, and the arterial or venous vessels are all considered illustrative examples of body spaces within the intended meaning.
- circumference or “circumferential”, including derivatives thereof, as used herein include a continuous path or line that forms an outer border or perimeter that surrounds and thereby defines an enclosed region of space.
- Such a continuous path starts at one location along the outer border or perimeter, and translates along the outer border or perimeter until it is completed at the original starting location to enclose the defined region of space.
- the related term "circumscribe,” including derivatives thereof, as used herein includes a surface to enclose, surround, or encompass a defined region of space. Therefore, a continuous line which is traced around a region of space and which starts and ends at substantially the same location "circumscribes" the region of space and has a “circumference” which includes the distance the line travels as it translates along the path circumscribing the space.
- a circumferential path or element may include one or more of several shapes, and may be for example circular, oblong, ovular, elliptical, or otherwise planar enclosures.
- a circumferential path may also be three dimensional, such as for example two opposite-facing semi-circular paths in two different parallel or off-axis planes that are connected at their ends by line segments bridging between the planes.
- Figures 1A-1D show circumferential paths 160, 162, 164, and 166, respectively.
- Each path 160, 162, 164, 166 translates along a portion of a body space, for example a pulmonary vein wall, and circumscribes a defined region of space, shown at 161, 163, 165, and 167, respectively, each circumscribed region of space being a portion of the body space.
- the circumferential path does not necessarily have to be translate along a tubular structure as shown, and other geometric structures are also contemplated, such as along the atrial wall in the atrium of a heart.
- the term "transect”, including derivatives thereof, as used herein includes a way to divide or separate a region of space into isolated regions.
- each of the regions circumscribed by the circumferential paths shown in Figures 1A-D transects the respective body space, for example the pulmonary vein, including its lumen and its wall, to the extent that the respective body space is divided into a first longitudinal region located on one side of the transecting region, shown for example at region "X" in Figure 1A, and a second longitudinal region on the other side of the transecting plane, shown for example at region "Y” also in Figure 1 A.
- a circumferential path along other structures, such as the atrial wall around the pulmonary vein ostium will transect the pulmonary vein from the atrium.
- a “circumferential conduction block” is formed along a region of tissue that follows a circumferential path, circumscribing the tissue region and transecting the region of tissue relative to electrical conduction along the circumferential path.
- the transecting circumferential conduction block therefore isolates electrical conduction between the left atrium and a pulmonary vein.
- abbreviations include the substantial altering of the mechanical, electrical, chemical, or other structural nature of tissue.
- ablation is intended to include sufficient altering of tissue properties to substantially block conduction of electrical signals from or through the ablated cardiac tissue.
- element within the context of “ablation element” is herein intended to include a discrete element, such as an ultrasonic transducer, or a plurality of discrete elements, such as a plurality of spaced ultrasonic transducers, which are positioned so as to collectively ablate a region of tissue. Therefore, an “ablation element” according to the defined terms can include a variety of specific structures adapted to ablate a defined region of tissue.
- one suitable ablation element for use in the present invention may be formed, according to the teachings of the embodiments below, from an "energy emitting" type of structure which is adapted to emit energy sufficient to ablate tissue when coupled to and energized by an energy source.
- One particular suitable "energy emitting" ablation element for use in the present invention may therefore include, for example an ultrasonic element such as an ultrasound crystal element which is adapted to emit ultrasonic sound waves sufficient to ablate tissue when coupled to a suitable excitation source.
- an ultrasonic element such as an ultrasound crystal element which is adapted to emit ultrasonic sound waves sufficient to ablate tissue when coupled to a suitable excitation source.
- the following describes ablation devices of a medical device system.
- the disclosed devices may include a position monitoring system that allows a clinician to precisely locate a distal end of the medical device within a body space by using feedback information provided by the system.
- Such feedback information is indicative of the position of the distal end of the medical device within the body space.
- the following devices of the position monitoring system are particularly well suited for applications involving positioning an ablation member at an area where a pulmonary vein extends from a left atrium and relative to a targeted circumferential region of tissue within the area, and therefore these devices are described in this context.
- Various aspects of the present invention can be readily adapted by those skilled in the art for applications involving positioning medical articles within other body spaces.
- catheter-based cardiac arrhythmia therapies generally involve introducing an ablation catheter into a cardiac chamber, such as in a percutaneous transluminal procedure, wherein an ablation element on the catheter's distal end portion is positioned at or adjacent to the aberrant conductive tissue.
- the ablation element is used to ablate the targeted tissue thereby creating a lesion.
- Figure 2 A shows an exemplary ablation catheter assembly 100 operably connected through an electrical connector 112 to an ablation control system 118.
- the catheter assembly 100 includes an elongated delivery member 102 with a proximal end portion 104 and a distal end portion 106.
- the distal end portion 106 supports an ablation member 128 including an ablation element 120 and an anchor mechanism 108.
- the anchor mechanism 108 is an expandable member.
- the expandable member can also include a sensor 109 that is explained below.
- the delivery member 102 desirably includes a plurality of lumens (some of which are illustrated in Figure 2B). Various wires and electrical leads are routed to the distal end portion 106 through at least some of these lumens. In a preferred device, these lumens generally run the length of the delivery member 102; however, for some applications, the lumens can be shorter.
- a guidewire 110 runs through a lumen in the delivery member 102 from the proximal end portion 104 to the distal end portion 106.
- the proximal end portion 104 also connects through a tube 113 to a screw connector 114. By introducing fluid into the tube 113 through the screw connector 114, a physician can inflate the expandable member 108, as known in the art.
- the delivery member 102 includes a distal port 121, which is distal to an ablation member 128.
- a proximal port 122 which is provided proximal of the ablation member 128.
- the proximal port 122 connects to a proximal port lumen 123
- the distal port 121 connects to a distal port lumen 124.
- the distal port 121 allows the clinician to introduce fluids into the patient, take fluid samples from the patient, and take fluid pressure reading on the distal side of the ablation member 128.
- the proximal port 122 allows the clinician to introduce fluids into the patient, take fluid samples from the patient, and take fluid pressure reading on the proximal side of the ablation member 128.
- These ports 121, 122 and lumens 123 and 124 are particularly useful when pressure or X-ray positioning techniques are employed, as explained below; however, the catheter assembly 100 need not include such ports and lumens when only an A-mode or Doppler position monitoring system is used with the catheter assembly.
- the delivery member 102 also includes a guidewire lumen 125 that is sized to track over the guidewire 110.
- the lumen 125 terminates at a distal port 127 located on the distal end 106 of the delivery member 102.
- the delivery member 102 desirably has an outer diameter provide within the range of from about 5 French to about 10 French, and more preferably from about 7 French to about 9 French.
- the guidewire lumen 125 preferably is adapted to slideably receive guidewires ranging from about 0.010 inch to about 0.038 inch in diameter, and preferably is adapted for use with guidewires ranging from about 0.018 inch to about 0.035 inch in diameter.
- the guidewire lumen 125 preferably has an inner diameter of 0.040 inch to about 0.042 inch.
- the delivery member 102 includes an inflation lumen 130 for use with an inflatable balloon (a preferred form of the expandable member 108)
- the inflation lumen 130 preferably has an inner diameter of about 0.020 inch in order to allow for rapid deflation times, although this may vary based upon the viscosity of inflation medium used, length of the lumen 130, and other dynamic factors relating to fluid flow and pressure.
- the delivery member J 02 for the illustrative application also is adapted to be introduced into the left atrium such that the distal end portion 106 can be placed within the pulmonary vein ostium in a percutaneous translumenal procedure, and even more preferably in a transeptal procedure as otherwise herein provided. Therefore, the distal end portion 106 is preferably flexible and adapted to track over and along a guidewire seated within the targeted pulmonary vein. In a further construction, the proximal end portion 104 is adapted to be at least 30% more stiff than the distal end portion 106.
- the proximal end portion 104 may be suitably adapted to provide push transmission to the distal end portion 106 while the distal end portion 106 is suitably adapted to track through bending anatomy during in vivo delivery of the distal end portion 106 of the device into the desired ablation region.
- other delivery mechanisms for delivering the ablation member 128 to the desired ablation region are also contemplated.
- Figure 2A variation is shown as an "over- the-wire" catheter construction
- other guidewire tracking designs are suitable substitutes, such as, for example, catheter devices that are known as “rapid exchange” or “monorail” variations, wherein the guidewire is only housed coaxially within a lumen of the catheter in the distal region of the catheter.
- a deflectable tip design may also be a suitable substitute to independently select a desired pulmonary vein and direct the transducer assembly into the desired location for ablation.
- the guidewire lumen and guidewire of the variation depicted in Figure 2A may be replaced with a "pullwire" lumen and associated fixed pullwire which is adapted to deflect the catheter tip by applying tension along varied stiffness transitions along the catheter's length.
- acceptable puUwires may have a diameter within the range from about 0.008 inch to about 0.020 inch, and may further include a taper, such as, for example, a tapered outer diameter from about 0.020 inch to about 0.008 inch.
- the distal end portion 106 of the delivery member supports an ablation member 128.
- the ablation member 128 includes an expandable member 108 and an ablation element 120.
- the expandable member 108 cooperates with the ablation element 120 to position and anchor the ablation element 120 relative to a circumferential region of tissue. Regions of tissue targeted for ablation may include, for example, a location where a pulmonary vein extends from the left atrium, including the back atrial wall of the left atrium, the pulmonary vein ostium or the pulmonary vein.
- the expandable member 108 is an inflatable balloon. The balloon has a diameter in a collapsed state roughly the same as the outer diameter of the delivery member distal end portion 106.
- the balloon 108 can be expanded to a diameter generally matching the diameter of the circumferential region of tissue, and may be expandable to a plurality of expanded positions in order to work with pulmonary vein ostia and/or pulmonary veins of various sizes. It is understood, however, that the ablation catheter assembly can also include other types of expandable members, such as, for example baskets, cages and like expandable structures.
- the expandable balloon 108 may be constructed from a variety of known materials, although the balloon preferably is adapted to conform to the contour of a pulmonary vein ostium and/or pulmonary vein lumenal wall.
- the balloon material can be of the highly compliant variety, such that the material elongates upon application of pressure and takes on the shape of the body lumen or space when fully inflated.
- Suitable balloon materials include elastomers, such as, for example, but without limitation, silicone, latex, or low durometer polyurethane (for example a durometer of about 80 A).
- the balloon can be formed to have a predefined fully inflated shape (i.e., be preshaped) to generally match the anatomic shape of the body lumen in which the balloon is inflated.
- the balloon can have a distally tapering shape to generally match the shape of a pulmonary vein ostium, and/or can include a bulbous proximal end to generally match a transition region of the atrium posterior wall adjacent to the pulmonary vein ostium.
- the balloon is preferably constructed to exhibit at least 300% expansion at 3 atmospheres of pressure, and more preferably to exhibit at least 400%) expansion at that pressure.
- expansion is herein intended to mean the balloon outer diameter after pressurization divided by the balloon inner diameter before pressurization, wherein the balloon inner diameter before pressurization is taken after the balloon is substantially filled with fluid in a taut configuration.
- expansion is herein intended to relate to the change in diameter that is attributable to the material compliance in a stress/strain relationship.
- the balloon is adapted to expand under a normal range of pressure such that its outer diameter may be adjusted from a radially collapsed position of about 5 millimeters to a radially expanded position of about 2.5 centimeters (or approximately 500%» expansion).
- the ablation element 120 cooperates with the expandable member 108 such that the ablation element 120 is held in a generally fixed position relative to the target circumferential region of tissue.
- the ablation element can be located outside or inside the expandable member, or can be located at least partially outside the expandable member.
- the ablation element in some forms, also includes a portion of the expandable member.
- the ablation catheter assembly in Figures 2A and 2B includes an ultrasonic transducer located within the expandable member 108. In one device, the ultrasonic transducer excites a portion of the expandable member 108 during ablation. The specific construction of the ultrasonic transducer and the associated construction of the delivery member shaft that supports the transducer, is described below.
- Figure 2B shows details of the distal end portion 106 of the catheter assembly 100 and, in particular, shows the ablation element 120 located circumferentially about an axial centerline of the delivery member 102.
- a plurality of wires 129 connect the ablation element 120 to a connector 112 at the proximal end of the catheter (shown in Figure 2A).
- the connector 112 is coupled to a corresponding cable of the ablation control system 118.
- the conductor lead can connect to all of the electrodes or energy sources, or separate conductors can be used so as to allow for independent control of each electrode or energy source under some modes of operation.
- FIG. 3 A A cross-section view showing construction of a typical single cylindrical ultrasonic transducer 300 having a cylindrical inner electrode 302, a cylindrical outer electrode 304, and a cylindrical piezoelectric material 303 between the electrodes is shown in Figure 3 A.
- the piezoelectric material 303 is a suitable material, such as, for example quartz, PZT, and the like, that exhibits a change in physical dimension in response to an impressed voltage.
- the piezoelectric material 303 is oriented such that when a voltage is impressed between the electrodes 302 and 304, the thickness of the piezoelectric material 303 changes slightly. When the polarity of the impressed voltage is alternated at an ultrasonic frequency F, the piezoelectric material 303 will vibrate at the ultrasonic frequency F.
- the vibrations of the piezoelectric material 303 produce ultrasonic sound waves. Since the electrodes are cylindrically symmetric, the piezoelectric material 303 will vibrate radially, with cylindrical symmetry. Conversely, when an ultrasonic wave hits the piezoelectric material 303, the ultrasonic wave will cause vibrations in the piezoelectric material. These vibrations will generate a voltage between the electrodes 302 and 304. Thus, the transducer is a reciprocal device that can both transmit and receive ultrasonic waves. A detailed construction for a cylindrical ultrasound transducer is shown in Figures 3B and 3C. The length of the transducer 300 or transducer assembly (e.g., multi-element array of transducer elements) desirably is selected for a given clinical application.
- the transducer length can fall within the range of approximately 80 mils up to greater than 395 mils, and preferably equals about 200 mils to 295 mils.
- a transducer accordingly sized is believed to form a lesion of a width sufficient to ensure the integrity of the formed conductive block without undue tissue ablation.
- the length can be significantly longer.
- the transducer outer diameter desirably is selected to account for delivery through a particular access path (e.g., percutaneously and transeptally), for proper placement and location within a particular body space, and for achieving a desired ablation effect.
- the transducer 300 preferably has an outer diameter within the range of about 70 mils to greater than 100 mils. It has been observed that a transducer with an outer diameter of about 80 mils generates acoustic power levels approaching 20 Watts per centimeter radiator or greater within myocardial or vascular tissue, which is believed to be sufficient for ablation of tissue engaged by the outer balloon for up to about 1.4 inches (3.5 cm) outer diameter of the balloon.
- the transducer 300 may have an outer diameter within the range of about 40 mils to greater than 120 to 160 mils (e.g., as large as 400 to 800 mils for applications in some body spaces).
- the central crystal layer 303 of the transducer 300 has a thickness selected to produce a desired operating frequency.
- the operating frequency will vary of course depending upon clinical needs, such as the tolerable outer diameter of the ablation and the depth of heating, as well as upon the size of the transducer as limited by the delivery path and the size of the target site.
- the transducer 300 in the illustrated application preferably operates within the range of about 5 MHz to about 20 MHz, and more preferably within the range of about 7 MHz to about 10 MHz.
- the transducer can have a thickness of approximately 12 mils for an operating frequency of about 7 MHz (i.e., a thickness generally equal to 1/2 the wavelength associated with the desired operating frequency).
- the transducer 300 is vibrated across the wall thickness and to radiate collimated acoustic energy in the radial direction.
- the distal ends of electrical leads 336, 337 are electrically coupled to outer and inner tubular members or electrodes 304, 302, respectively, of the transducer 300, such as, for example, by soldering the leads to the metallic coatings or by resistance welding.
- the electrical leads are 4-8 mil (0.004 to 0.008 inch diameter) silver wire or the like.
- the proximal ends of these leads are adapted to couple to an ultrasonic driver or actuator 340, which is schematically illustrated in Figure 3B.
- the transducer 300 also can be sectored by etching or notching grooves in the outer transducer electrode 304 and part of the central piezoelectric crystal layer 303 along lines parallel to the longitudinal axis L of the transducer 300, as illustrated in Figure 3C.
- the sectoring substantially electrically isolates the outer transducer electrode 304, creating in effect separate transducers.
- a separate electrical lead connects to each sector in order to couple the sector to a dedicated power control that individually excites the corresponding transducer sector.
- the ultrasonic driver 340 can enhance the uniformity of the acoustic energy beam around the transducer 300, as well as can vary the degree of heating (i.e., lesion control) in the angular dimension.
- FIGS. 3D and 3E illustrate the collimated radial acoustical energy beam paths 320 when the ablation device is placed in a pulmonary vein 325 and pulmonary vein ostium 330, respectively.
- the present invention utilizes a tissue ablation element and device assembly capable of creating a circular energy beam that can be phased in the longitudinal direction, orienting the beam forward or backward.
- the ablation element is a thin wall ultrasonic transducer sectioned into a small number of intertwined helical transducer segments with many turns forming a spiral array.
- FIGS. 4A through 4C are perspective, side and end views, respectively, showing the construction of a spiral array of ultrasonic transducers segments according to one embodiment of the present invention.
- the array is made from a single tube shaped piezoelectric transducer 400 having a longitudinal axis 410.
- the transducer 400 comprises a piezoelectric crystal 403 between an inner electrode 402, and an outer electrode 404.
- the transducer 400 is approximately 325 mils long with an outside diameter of approximately 100 mils, and a wall thickness of approximately 18 mils.
- the outer electrode 404 is segmented by etched grooves into a small number of intertwined individual helical elements 405 having a plurality of turns.
- Each individual element 405 is substantially electrically insulated from the other elements, allowing the segmented elements to operate independently with minimal interference.
- This configuration in effect essentially forms an array of helically shaped functionally discrete transducers arranged linearly along the longitudinal axis 410.
- these apparent functionally discrete transducers will be referred to as transducer segments.
- the helical phased array configuration allows the transducer 400 to achieve a phase coherency equal to many more individual serially phased transducers placed axially along the longitudinal axis 410.
- the illustrated embodiment shows a transducer 400 having an outer electrode 404 sectored into five (5) elements 405 (405a through 405e) corresponding to five (5) discrete transducer segments 400a through 400e.
- Each transducer segment 400a through 400e encompasses twenty (20) turns, providing the phasing coherency of approximately one hundred (100) separate phased transducers arranged serially along the longitudinal axis 410.
- the number of elements 405, transducer segments (400a through 400e), and turns illustrated is exemplary.
- One of skill in the art would understand that other configurations are contemplated by the present invention having more or fewer helical elements 405. Several factors, including the desired application, may contribute to these other configurations.
- Each individual helical element 405 has an enlarged element pad 406 (406a through 406e) that serves as a connection point for the lead wires (not shown) used to energize the individual transducer segments (400a through 400e respectively).
- Each of these element pads 406 is substantially electrically insulated from one another to limit interference between individual elements 405.
- a ground pad 407 is attached to the inner electrode 402 and provides a connection point for a ground wire.
- the illustrated embodiment has six (6) pads (five element pads 406a - 406e and one ground pad 407). Each pad is equally spaced around the circumference of the transducer 400, approximately sixty (60) degrees from each other. However, this configuration should not be read to limit the scope of the invention.
- each element pad 406 be substantially electrically insulated from one another other to minimize interference and cross-talk between elements 405, regardless of the configuration.
- attachment of the lead and ground wires is by soldering the wires directly to the element and ground pads 406, 407 respectively.
- the segment (400a through 400e) associated with the particular end pad 406 is energized.
- the transducer 400 is sectioned into a small number of intertwined individual helical transducer segments (400a through 400e) that are substantially electrically insulated from one another by grooves etched through at least the outer electrode 404.
- FIG. 8 is a flow diagram illustrating the method steps for making transducer 400 having a plurality of transducer segments 400a through 400e according to one embodiment of the present invention.
- the PZT ceramic material blank is provided (step 800) and core drilled and machined using a computer numerical control machine (CNC machine) into a tubular configuration as shown in step 805.
- the machined tube will have an inside diameter of approximately 100 mils and an outside diameter of approximately 120 mils, providing a wall thickness of approximately 10 mils.
- the overall length of the PZT ceramic cylinder is also machined to approximately 325 mils. Concentricity should be under 1 mil at each end of the tube.
- This tubular PZT ceramic material forms what will ultimately become piezoelectric material 403.
- a quadruple YAG laser at about 700 nanometer wavelength, hooked to a rotary mandrel CAD/CAM machine is used to machine the PZT ceramic material blank into the tubular configuration.
- the outer surface of the PZT cylinder 403 is then polished using methods known in the art as shown in step 810.
- One method acceptable to polish the PZT cylinder 403 involves mounting the cylinder 403 on a spinning mandrel and spinning the mandrel at a high speed, at which time the cylinder 403 is contacted with a very fine abrasive material, such as sandpaper or cloth. Rotational speeds of approximately 30,000 RPM or more have been found to be acceptable.
- the polished finish creates a very fine, smooth surface that facilitates subsequent metallic deposition that forms the electrodes.
- the polished surface lessens the- chance of cracks or defects in the metallic electrode surface, resulting in a very uniform and even metallic layer.
- the uniform metallic layer enables subsequent etching or notching of very fine grooves or patterns.
- a polished mirror finish of 10 microns or less will allow the laser etching process to yield grooves of 30 to 50 microns.
- the tubular PZT ceramic material 403 is then coated with one or more metallic layers to form the inner and outer electrodes 402, 404 respectively as shown in step 815.
- the PZT ceramic material 403 is first sputtered with Gold and then Nickel-plated.
- coated PZT tube 403 is rotated and flipped during the process to ensure adequate Gold coverage from all directions.
- the coated PZT tube 403 is plated using a plating process.
- coated PZT tube 403 is Nickel plated by immersing the tube 403 in a solution of Nickel and acid. Using a small electric current, the Nickel is brought out of the solution and is deposited onto the exposed surfaces of the tube.
- patterns, such as the spiral grooves forming the helical elements 405 are etched or notched into the surface of the transducer, the transducer becomes extremely fragile.
- the transducer assembly 400 is mounted on a mandrel prior to machining the grooves as shown in step 820.
- the mandrel provides additional structural support until a matching layer, described below, is place over the transducer assembly 400.
- the metallic coated tube is then machined to form the inner and outer electrodes 402, 404 respectively as shown in step 825.
- the machine process to form the electrodes 402, 404 comprises laser etching the metallic coating.
- the combination of these materials (402, 403, 404) form transducer 400. Both metal coating procedures are well known in the art, and may use other metals, other than Gold and Nickel in the process.
- the sputtering process may be eliminated when fabricating ultrasound transducers.
- Segmentation of the transducer 400 may be accomplished by etching or notching spiral grooves into at least the outer electrode 404 of transducer 400, separating the transducer 400 into functioning discrete transducer segments (400a through 400e) as shown in step 830.
- the grooves can be made using several different methods known in the art, such as for example etching using a diamond wheel or laser.
- One particular laser machining method that may be adapted to cut helical grooves is disclosed by Corbett, Scott et al.
- Poling is known in the art and refers to the process of orienting the molecules of the PZT ceramic material, essentially transforming the PZT ceramic material into a piezoelectric crystal. Poling is achieved by heating the PZT ceramic material beyond its Kerrie point and applying a strong electric field. In one embodiment of the present invention, the PZT ceramic material is heated to approximately 500 degrees C while an electric field of approximately 500 volts DC is applied. There is no need to pole each transducer segment (400a through 400e) separately. Instead, it would be sufficient to short all five segments, and apply the voltage between all five transducer elements 405a through 405e and the ground electrode 402 together. A multi-coaxial wire is then attached to the transducer 400 as shown in step
- the matching layer also increases the bandwidth of each transducer segment (400a through 400e), and thus the transducer's (400) overall bandwidth. As described in greater detail below, this characteristic provides a greater frequency operating range for each transducer segment 400a through 400e.
- To project the acoustic energy beam forward or backward relative to the transducer 400 longitudinal axis requires the transducer segments 400a through 400e to be operated out of phase from one another. Any desired change to be made to the acoustic energy beam angle is proportionally related to the frequency. Accordingly, the greater the bandwidth of the transducer segments 400a through 400e, the greater the spectrum (wider angle) the transducer 400 can project the acoustic energy beam.
- the matching layer also provides electrical insulation between the transducer elements 405.
- the matching layer is formed from a polymer laminated over the transducer elements 405, leaving the grooves separating the transducer elements 405 filled with air.
- This configuration provides acoustic separation between transducer segments 400a through 400e and insures a uniform thickness of the matching layer.
- the impressed voltage between adjacent transducer segments 400a through 400e may be relatively high. This high voltage coupled with the relatively long distance the adjacent transducer elements 405 run in parallel increase the risk of current leakage between adjacent transducer segments 400a through 400e.
- the air-filled grooves provide little or no resistance to this leakage.
- the piezoelectric material 503 is a single piece of un-sectioned material as shown in Figures 5A and 5B, so the impressed voltage and subsequent vibration between the inner electrode 502 and the outer electrode element 505a will cause some vibration in the regions between the inner electrode 502 and outer electrode elements 505b and 505e adjacent to electrode element 505a.
- This coupling of signals is sometimes referred to a cross-talk. Excessive cross-talk between electrodes may be undesirable for some particular applications.
- the elements may be partially isolated from one another.
- Figures 6A and 6B are section and close-up section views respectively showing the construction of a transducer 600 having grooves extended into the cylindrical piezoelectric material 603 according to one embodiment of the present invention.
- the transducers 500, 600 may be operated in at least two modes. In a first mode, all five transducer segments (simulating five helical transducers) are driven with identical signals. This mode will create a single radial acoustic energy beam having a radial thickness similar to existing single transducer designs. In a second mode, the five individual segments are driven as a standard phased array by signals having a fixed phased delay between segments. Because the segments are arranged to simulate five helical transducers, the phased array allows the resultant energy beam to be directed forward or backward. A phased delay is a representation of the time delay in seconds experienced by each sinusoidal component of the input signal. The phase of a periodic phenomenon i.e.
- the transducer segments 700a through 700e are driven through a five-channel generator with five leads.
- One advantage of the illustrated configuration is that it can generate a coherent phased acoustic energy beam that simulates over fifty individual elements.
- like reference numerals are used to show the association between particular fixed phase input signals 720a through 720e, transducer elements 705a through 705e, and transducer signals 700a through 700e.
- transducer element 705a produces sinusoidal ultrasonic sound wave 720a.
- Figure 7B is a schematic representation illustrating resultant cumulative acoustic energy beams (750, 751, 752) emanating from each of the plurality of transducer element 705a when driven at different frequencies.
- A is the wavelength of the input signal
- V is the speed of sound in water (1550 m/sec);
- FIG. 7C is a side view of an ablation catheter showing the acoustical energy beam paths 751 projected at an angle relative to the transducer longitudinal axis when the ablation device is placed at the juncture between a body lumen and a body cavity, such as a pulmonary vein ostium 330.
- an acoustical energy beam can be projected at an angle 90° (i.e.
- the amplifiers should have a bandwidth of up to 12 MHz and should have identical gain and phase shift across the channels.
- the generator should preferably have directional couplers, shunt resistors to dissipate reflected power, and sensing circuits for reflected power magnitude and phase.
- the signal generator would be a computer driven signal generator capable of generating highly coherent continuous sine wave signals with accurate phase delay between the channels.
- the computer should be capable of obtaining the desired angle as an input, and calculate the frequency and phase for each of the five channels.
- Other desirable inputs to the computer should include the desirable output power, the direct and reflected power of each channel, and the target tissue temperature.
- the foregoing invention variously shows circumferential ablation device assemblies incorporating ultrasound transducers for ablating a circumferential region of tissue.
- Such ultrasound ablation assemblies are believed to be particularly amenable to use with the position monitoring assemblies incorporating sensing capabilities of the ablation transducer itself, such as for example but not limited to an "A"-mode sensing system.
- the particular ablation devices may also be combined with the other position monitoring assemblies and related sensors.
- such ultrasound ablation assemblies may also be combined with the various ablation monitoring assemblies, such as temperature monitoring assemblies and sensors.
- a source of acoustic energy is provided with a delivery device that may also includes an anchoring mechanism.
- the anchoring device comprises an expandable member that also positions the acoustic energy source within the body; however, other anchoring and positioning devices may also be used, such as, for example, a basket mechanism.
- the acoustic energy source is located within the expandable member and the expandable member is adapted to engage a circumferential path of tissue either about or along a pulmonary vein in the region of its ostium along a left atrial wall.
- an ultrasonic transducer can form a lesion, which has about a 1.5 mm width, about a 2.5 mm diameter lumen, such as a pulmonary vein and of a sufficient depth to form an effective conductive block. It is believed that an effective conductive block can be formed by producing a lesion within the tissue that is transmural or substantially transmural. Depending upon the patient as well as the location within the pulmonary vein ostium, the lesion may have a depth of 1 millimeter to 10 millimeters. It has been observed that the ultrasonic transducer can be powered to provide a lesion having these parameters so as to form an effective conductive block between the pulmonary vein and the posterior wall of the left atrium.
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Mechanical Engineering (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Manufacturing & Machinery (AREA)
- Physics & Mathematics (AREA)
- Acoustics & Sound (AREA)
- Signal Processing (AREA)
- Surgical Instruments (AREA)
- Transducers For Ultrasonic Waves (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2533212A CA2533212C (en) | 2003-07-21 | 2004-07-20 | Method for making a spiral array ultrasound transducer |
AU2004258954A AU2004258954A1 (en) | 2003-07-21 | 2004-07-20 | Method for making a spiral array ultrasound transducer |
AT04778706T ATE510489T1 (en) | 2003-07-21 | 2004-07-20 | METHOD FOR PRODUCING A SPIRAL ULTRASONIC TRANSDUCER ARRANGEMENT |
EP04778706A EP1646309B1 (en) | 2003-07-21 | 2004-07-20 | Method for making a spiral array ultrasound transducer |
JP2006521190A JP4685013B2 (en) | 2003-07-21 | 2004-07-20 | Manufacturing method of helical array ultrasonic transducer |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/623,894 | 2003-07-21 | ||
US10/623,894 US7247269B2 (en) | 2003-07-21 | 2003-07-21 | Method for making a spiral array ultrasound transducer |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005009219A2 true WO2005009219A2 (en) | 2005-02-03 |
WO2005009219A3 WO2005009219A3 (en) | 2005-09-09 |
Family
ID=34079875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/023332 WO2005009219A2 (en) | 2003-07-21 | 2004-07-20 | Method for making a spiral array ultrasound transducer |
Country Status (7)
Country | Link |
---|---|
US (1) | US7247269B2 (en) |
EP (1) | EP1646309B1 (en) |
JP (1) | JP4685013B2 (en) |
AT (1) | ATE510489T1 (en) |
AU (2) | AU2004258954A1 (en) |
CA (1) | CA2533212C (en) |
WO (1) | WO2005009219A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10076384B2 (en) | 2013-03-08 | 2018-09-18 | Symple Surgical, Inc. | Balloon catheter apparatus with microwave emitter |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7670335B2 (en) * | 2003-07-21 | 2010-03-02 | Biosense Webster, Inc. | Ablation device with spiral array ultrasound transducer |
US20060054604A1 (en) * | 2004-09-10 | 2006-03-16 | Saunders Richard J | Laser process to produce drug delivery channel in metal stents |
US10413284B2 (en) | 2006-11-07 | 2019-09-17 | Corvia Medical, Inc. | Atrial pressure regulation with control, sensing, monitoring and therapy delivery |
AU2007317191B2 (en) | 2006-11-07 | 2014-02-20 | Corvia Medical, Inc. | Devices and methods for the treatment of heart failure |
US20110257723A1 (en) | 2006-11-07 | 2011-10-20 | Dc Devices, Inc. | Devices and methods for coronary sinus pressure relief |
US9232997B2 (en) | 2006-11-07 | 2016-01-12 | Corvia Medical, Inc. | Devices and methods for retrievable intra-atrial implants |
US20080146937A1 (en) * | 2006-12-14 | 2008-06-19 | General Electric Company | Mechanically expanding transducer assembly |
US9474571B2 (en) * | 2007-10-15 | 2016-10-25 | Boston Scientific Scimed, Inc. | Percutaneous tissue ablation probe with occlusive bodies |
US20100036294A1 (en) | 2008-05-07 | 2010-02-11 | Robert Mantell | Radially-Firing Electrohydraulic Lithotripsy Probe |
WO2009152352A2 (en) | 2008-06-13 | 2009-12-17 | Aspen Medtech, Inc. | Shockwave balloon catheter system |
US9072534B2 (en) | 2008-06-13 | 2015-07-07 | Shockwave Medical, Inc. | Non-cavitation shockwave balloon catheter system |
US10702293B2 (en) | 2008-06-13 | 2020-07-07 | Shockwave Medical, Inc. | Two-stage method for treating calcified lesions within the wall of a blood vessel |
US9180280B2 (en) * | 2008-11-04 | 2015-11-10 | Shockwave Medical, Inc. | Drug delivery shockwave balloon catheter system |
US9044618B2 (en) | 2008-11-05 | 2015-06-02 | Shockwave Medical, Inc. | Shockwave valvuloplasty catheter system |
US9757107B2 (en) | 2009-09-04 | 2017-09-12 | Corvia Medical, Inc. | Methods and devices for intra-atrial shunts having adjustable sizes |
CN102905626A (en) | 2010-01-29 | 2013-01-30 | Dc设备公司 | Devices and systems for treating heart failure |
CA2785041A1 (en) * | 2010-01-29 | 2011-08-04 | Dc Devices, Inc. | Devices and methods for reducing venous pressure |
US20130245444A1 (en) * | 2010-09-22 | 2013-09-19 | Wavomed Ltd. | Synchronously pumped ultrasonic waves and shear wave generation by same |
GB201016530D0 (en) * | 2010-09-30 | 2010-11-17 | Zephyros Inc | Improvements in or relating to adhesives |
EP2673038B1 (en) * | 2011-02-10 | 2017-07-19 | Corvia Medical, Inc. | Apparatus to create and maintain an intra-atrial pressure relief opening |
WO2012120495A2 (en) * | 2011-03-04 | 2012-09-13 | Rainbow Medical Ltd. | Tissue treatment and monitoring by application of energy |
KR101212958B1 (en) | 2011-04-18 | 2012-12-18 | 한국과학기술원 | Energy Harvesting System Using Elastic Body Covered Ferroelectricity Fabricated Dip Coating Method |
US8574247B2 (en) | 2011-11-08 | 2013-11-05 | Shockwave Medical, Inc. | Shock wave valvuloplasty device with moveable shock wave generator |
US9205236B2 (en) | 2011-12-22 | 2015-12-08 | Corvia Medical, Inc. | Methods, systems, and devices for resizable intra-atrial shunts |
US9642673B2 (en) | 2012-06-27 | 2017-05-09 | Shockwave Medical, Inc. | Shock wave balloon catheter with multiple shock wave sources |
EP2879597B1 (en) | 2012-08-06 | 2016-09-21 | Shockwave Medical, Inc. | Shockwave catheter |
EP2879607B1 (en) | 2012-08-06 | 2019-02-27 | Shockwave Medical, Inc. | Low profile electrodes for an angioplasty shock wave catheter |
US9138249B2 (en) | 2012-08-17 | 2015-09-22 | Shockwave Medical, Inc. | Shock wave catheter system with arc preconditioning |
US9333000B2 (en) | 2012-09-13 | 2016-05-10 | Shockwave Medical, Inc. | Shockwave catheter system with energy control |
US9522012B2 (en) | 2012-09-13 | 2016-12-20 | Shockwave Medical, Inc. | Shockwave catheter system with energy control |
CA3160475A1 (en) | 2013-03-11 | 2014-09-18 | Northgate Technologies Inc. | Unfocused electrohydraulic lithotripter |
US10561862B2 (en) * | 2013-03-15 | 2020-02-18 | Guided Therapy Systems, Llc | Ultrasound treatment device and methods of use |
WO2014179886A1 (en) * | 2013-05-08 | 2014-11-13 | Dalhousie University | Acoustic transmitter and implantable receiver |
US10675450B2 (en) | 2014-03-12 | 2020-06-09 | Corvia Medical, Inc. | Devices and methods for treating heart failure |
US9730715B2 (en) | 2014-05-08 | 2017-08-15 | Shockwave Medical, Inc. | Shock wave guide wire |
EP3171786B1 (en) | 2014-07-23 | 2020-05-13 | Corvia Medical, Inc. | Devices for treating heart failure |
WO2017087195A1 (en) | 2015-11-18 | 2017-05-26 | Shockwave Medical, Inc. | Shock wave electrodes |
US10226265B2 (en) | 2016-04-25 | 2019-03-12 | Shockwave Medical, Inc. | Shock wave device with polarity switching |
AU2017339980B2 (en) | 2016-10-06 | 2022-08-18 | Shockwave Medical, Inc. | Aortic leaflet repair using shock wave applicators |
US10357264B2 (en) | 2016-12-06 | 2019-07-23 | Shockwave Medical, Inc. | Shock wave balloon catheter with insertable electrodes |
CN110114000A (en) * | 2016-12-19 | 2019-08-09 | 皇家飞利浦有限公司 | The ultrasonic guidance of actuatable medical tool |
US11225961B2 (en) * | 2017-02-21 | 2022-01-18 | Sensus Spectrum, Llc | Multi-element bending transducers and related methods and devices |
US10441300B2 (en) | 2017-04-19 | 2019-10-15 | Shockwave Medical, Inc. | Drug delivery shock wave balloon catheter system |
US11020135B1 (en) | 2017-04-25 | 2021-06-01 | Shockwave Medical, Inc. | Shock wave device for treating vascular plaques |
WO2018204692A1 (en) | 2017-05-03 | 2018-11-08 | Medtronic Vascular, Inc. | Tissue-removing catheter |
US11690645B2 (en) | 2017-05-03 | 2023-07-04 | Medtronic Vascular, Inc. | Tissue-removing catheter |
US10966737B2 (en) | 2017-06-19 | 2021-04-06 | Shockwave Medical, Inc. | Device and method for generating forward directed shock waves |
US10709462B2 (en) | 2017-11-17 | 2020-07-14 | Shockwave Medical, Inc. | Low profile electrodes for a shock wave catheter |
WO2019245746A1 (en) | 2018-06-21 | 2019-12-26 | Shockwave Medical, Inc. | System for treating occlusions in body lumens |
EP3880096A1 (en) | 2018-11-16 | 2021-09-22 | Medtronic Vascular Inc. | Tissue-removing catheter |
US11819236B2 (en) | 2019-05-17 | 2023-11-21 | Medtronic Vascular, Inc. | Tissue-removing catheter |
US11478261B2 (en) | 2019-09-24 | 2022-10-25 | Shockwave Medical, Inc. | System for treating thrombus in body lumens |
CN111317431B (en) * | 2020-03-11 | 2022-10-04 | 陕西吾方医疗科技有限公司 | Upper gastrointestinal tract treatment endoscope |
US11992232B2 (en) | 2020-10-27 | 2024-05-28 | Shockwave Medical, Inc. | System for treating thrombus in body lumens |
US12023098B2 (en) | 2021-10-05 | 2024-07-02 | Shockwave Medical, Inc. | Lesion crossing shock wave catheter |
WO2023205437A1 (en) * | 2022-04-22 | 2023-10-26 | North Carolina State University | Intravascular/endovascular ultrasound transducers capable of generating swirling acoustic field |
US12035932B1 (en) | 2023-04-21 | 2024-07-16 | Shockwave Medical, Inc. | Intravascular lithotripsy catheter with slotted emitter bands |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4135109A (en) | 1977-09-09 | 1979-01-16 | Westinghouse Electric Corp. | High powered piezoelectric cylindrical transducer with threads cut into the wall |
Family Cites Families (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1491905A (en) * | 1918-06-21 | 1924-04-29 | Alfred L Eustice | Inclosed electric fuse |
US2308435A (en) * | 1941-01-11 | 1943-01-12 | Chase Shawmut Co | Electric fuse |
US2863967A (en) * | 1957-04-26 | 1958-12-09 | Chase Shawmut Co | Current-limiting power fuses of reduced size |
US3035126A (en) * | 1957-12-27 | 1962-05-15 | William W Haeffiger | Transducer |
US3189712A (en) * | 1963-02-18 | 1965-06-15 | Chase Shawmut Co | High interrupting capacity fuse |
US3261950A (en) * | 1964-11-30 | 1966-07-19 | Chase Shawmut Co | Time-lag fuses having high thermal efficiency |
US3301978A (en) * | 1965-09-20 | 1967-01-31 | Mc Graw Edison Co | Protectors for electric circuits |
US3529271A (en) * | 1968-08-06 | 1970-09-15 | Chase Shawmut Co | Electric cartridge fuses having blade contacts |
US3629036A (en) * | 1969-02-14 | 1971-12-21 | Shipley Co | The method coating of photoresist on circuit boards |
US3786402A (en) * | 1972-10-26 | 1974-01-15 | Molex Inc | Electrical terminal |
US3935553A (en) * | 1974-01-03 | 1976-01-27 | Kozacka Frederick J | Cartridge fuse for d-c circuits |
US3909767A (en) * | 1974-01-14 | 1975-09-30 | Littelfuse Inc | Miniature plug-in fuse |
US4056884A (en) * | 1975-02-08 | 1977-11-08 | Littelfuse, Inc. | Method of making a miniature plug-in fuse |
US4059334A (en) * | 1976-06-17 | 1977-11-22 | Eltra Corporation | Blade type fuse clip assembly |
US4069076A (en) * | 1976-11-29 | 1978-01-17 | E. I. Du Pont De Nemours And Company | Liquid lamination process |
US4203200A (en) * | 1977-08-01 | 1980-05-20 | Wiebe Gerald L | Method and apparatus for making an encapsulated plug-in blade fuse |
US4099828A (en) * | 1977-10-07 | 1978-07-11 | General Electric Company | Blade-type fuse clip with field installable rejection means |
US4224592A (en) * | 1978-04-03 | 1980-09-23 | Mcgraw-Edison Company | Miniature plug-in fuse assembly and method of manufacture |
US4300281A (en) * | 1978-08-08 | 1981-11-17 | Gould Inc. | Method of making electric fuse having folded fusible element and heat dams |
US4221456A (en) * | 1979-03-01 | 1980-09-09 | Ford Motor Company | Fuse holder for an automotive fuse terminal block |
US4221455A (en) * | 1979-03-01 | 1980-09-09 | Ford Motor Company | Fuse terminal block with alternative means for connection to fuse blade contacts |
US4292321A (en) * | 1979-05-24 | 1981-09-29 | Warner-Lambert Company | 1,3,8-Triazaspirodecane-4-ones, pharmaceutical compositions thereof and method of use thereof |
US4414526A (en) * | 1979-07-30 | 1983-11-08 | Gould Inc. | Electric fuse having composite fusible element |
EP0041966A1 (en) * | 1979-12-03 | 1981-12-23 | Kenneth E Beswick Limited | Method of manufacturing plug-in electrical fuses and a fuse produced by the method |
US4343530A (en) * | 1980-01-10 | 1982-08-10 | Honeywell Information Systems Inc. | Wave solderable quick disconnect male terminal for printed circuit boards |
US4449528A (en) | 1980-03-20 | 1984-05-22 | University Of Washington | Fast pulse thermal cautery probe and method |
US4344058A (en) * | 1980-09-02 | 1982-08-10 | Gould, Inc. | Low voltage cartridge fuse design |
US4522205A (en) | 1980-09-03 | 1985-06-11 | The University Court Of The University Of Edinburgh | Therapeutic device and method of inducing thrombosis in a blood vessel |
US4673563A (en) | 1980-10-14 | 1987-06-16 | The University Of Virginia Alumni Patents Foundation | Adenosine in the treatment of supraventricular tachycardia |
US4391485A (en) * | 1981-01-09 | 1983-07-05 | Mcgraw-Edison Company | In-line fuse holder for miniature plug-in fuse |
US4375630A (en) * | 1981-04-01 | 1983-03-01 | Mcgraw-Edison Company | Multiple element current limiting fuse |
DE3115435A1 (en) * | 1981-04-16 | 1982-11-11 | Grote & Hartmann Gmbh & Co Kg, 5600 Wuppertal | "FLAT FUSE AND METHOD FOR THEIR PRODUCTION" |
CA1244889A (en) | 1983-01-24 | 1988-11-15 | Kureha Chemical Ind Co Ltd | Device for hyperthermia |
US4662368A (en) | 1983-06-13 | 1987-05-05 | Trimedyne Laser Systems, Inc. | Localized heat applying medical device |
US4672962A (en) | 1983-09-28 | 1987-06-16 | Cordis Corporation | Plaque softening method |
US4569801A (en) | 1984-10-15 | 1986-02-11 | Eli Lilly And Company | Alkylsulfonamidophenylalkylamines |
US5226430A (en) | 1984-10-24 | 1993-07-13 | The Beth Israel Hospital | Method for angioplasty |
US4641649A (en) | 1985-10-30 | 1987-02-10 | Rca Corporation | Method and apparatus for high frequency catheter ablation |
US4790311A (en) | 1986-06-03 | 1988-12-13 | Ruiz Oscar F | Radio frequency angioplasty catheter system |
US4807620A (en) | 1987-05-22 | 1989-02-28 | Advanced Interventional Systems, Inc. | Apparatus for thermal angioplasty |
US4998933A (en) | 1988-06-10 | 1991-03-12 | Advanced Angioplasty Products, Inc. | Thermal angioplasty catheter and method |
US4938217A (en) | 1988-06-21 | 1990-07-03 | Massachusetts Institute Of Technology | Electronically-controlled variable focus ultrasound hyperthermia system |
US4898591A (en) | 1988-08-09 | 1990-02-06 | Mallinckrodt, Inc. | Nylon-PEBA copolymer catheter |
US5035694A (en) | 1989-05-15 | 1991-07-30 | Advanced Cardiovascular Systems, Inc. | Dilatation catheter assembly with heated balloon |
USD321683S (en) * | 1989-07-10 | 1991-11-19 | Cooper Industries, Inc. | Blade-type fuse block |
US5104393A (en) | 1989-08-30 | 1992-04-14 | Angelase, Inc. | Catheter |
US5078736A (en) | 1990-05-04 | 1992-01-07 | Interventional Thermodynamics, Inc. | Method and apparatus for maintaining patency in the body passages |
US5190540A (en) | 1990-06-08 | 1993-03-02 | Cardiovascular & Interventional Research Consultants, Inc. | Thermal balloon angioplasty |
US5178618A (en) | 1991-01-16 | 1993-01-12 | Brigham And Womens Hospital | Method and device for recanalization of a body passageway |
US5314466A (en) | 1992-04-13 | 1994-05-24 | Ep Technologies, Inc. | Articulated unidirectional microwave antenna systems for cardiac ablation |
US5562720A (en) | 1992-05-01 | 1996-10-08 | Vesta Medical, Inc. | Bipolar/monopolar endometrial ablation device and method |
US5295484A (en) | 1992-05-19 | 1994-03-22 | Arizona Board Of Regents For And On Behalf Of The University Of Arizona | Apparatus and method for intra-cardiac ablation of arrhythmias |
JPH06120062A (en) | 1992-10-06 | 1994-04-28 | Taiyo Yuden Co Ltd | Manufacture of cylindrical ceramic inductor |
US5348554A (en) | 1992-12-01 | 1994-09-20 | Cardiac Pathways Corporation | Catheter for RF ablation with cooled electrode |
US5545161A (en) | 1992-12-01 | 1996-08-13 | Cardiac Pathways Corporation | Catheter for RF ablation having cooled electrode with electrically insulated sleeve |
US5636634A (en) | 1993-03-16 | 1997-06-10 | Ep Technologies, Inc. | Systems using guide sheaths for introducing, deploying, and stabilizing cardiac mapping and ablation probes |
US5392259A (en) * | 1993-06-15 | 1995-02-21 | Bolorforosh; Mir S. S. | Micro-grooves for the design of wideband clinical ultrasonic transducers |
US5449380A (en) | 1993-09-17 | 1995-09-12 | Origin Medsystems, Inc. | Apparatus and method for organ ablation |
US5582609A (en) | 1993-10-14 | 1996-12-10 | Ep Technologies, Inc. | Systems and methods for forming large lesions in body tissue using curvilinear electrode elements |
US5545193A (en) | 1993-10-15 | 1996-08-13 | Ep Technologies, Inc. | Helically wound radio-frequency emitting electrodes for creating lesions in body tissue |
US5575810A (en) | 1993-10-15 | 1996-11-19 | Ep Technologies, Inc. | Composite structures and methods for ablating tissue to form complex lesion patterns in the treatment of cardiac conditions and the like |
WO1995010322A1 (en) | 1993-10-15 | 1995-04-20 | Ep Technologies, Inc. | Creating complex lesion patterns in body tissue |
US5427119A (en) | 1993-11-03 | 1995-06-27 | Daig Corporation | Guiding introducer for right atrium |
US5564440A (en) | 1993-11-03 | 1996-10-15 | Daig Corporation | Method for mopping and/or ablation of anomalous conduction pathways |
US5575766A (en) | 1993-11-03 | 1996-11-19 | Daig Corporation | Process for the nonsurgical mapping and treatment of atrial arrhythmia using catheters guided by shaped guiding introducers |
US5487385A (en) | 1993-12-03 | 1996-01-30 | Avitall; Boaz | Atrial mapping and ablation catheter system |
US5497119A (en) | 1994-06-01 | 1996-03-05 | Intel Corporation | High precision voltage regulation circuit for programming multilevel flash memory |
USD373570S (en) * | 1994-06-01 | 1996-09-10 | Yazaki Corporation | Fuse |
US5617854A (en) | 1994-06-22 | 1997-04-08 | Munsif; Anand | Shaped catheter device and method |
US5575788A (en) | 1994-06-24 | 1996-11-19 | Stuart D. Edwards | Thin layer ablation apparatus |
US5505730A (en) | 1994-06-24 | 1996-04-09 | Stuart D. Edwards | Thin layer ablation apparatus |
US5681308A (en) | 1994-06-24 | 1997-10-28 | Stuart D. Edwards | Ablation apparatus for cardiac chambers |
DE69531833T2 (en) | 1994-10-07 | 2004-07-15 | Boston Scientific Ltd., St. Michael | FLEXIBLE ELECTRODE STRUCTURE |
WO1996026675A1 (en) | 1995-02-28 | 1996-09-06 | Boston Scientific Corporation | Deflectable catheter for ablating cardiac tissue |
DE69532046T2 (en) | 1995-04-20 | 2004-06-24 | Desai, Jawahar M., Roseville | DEVICE FOR MULTI-DIMENSIONAL DISPLAY AND TISSUE ABLATION OF THE HEART |
US5688267A (en) | 1995-05-01 | 1997-11-18 | Ep Technologies, Inc. | Systems and methods for sensing multiple temperature conditions during tissue ablation |
US5702438A (en) | 1995-06-08 | 1997-12-30 | Avitall; Boaz | Expandable recording and ablation catheter system |
US5590657A (en) | 1995-11-06 | 1997-01-07 | The Regents Of The University Of Michigan | Phased array ultrasound system and method for cardiac ablation |
US5800482A (en) | 1996-03-06 | 1998-09-01 | Cardiac Pathways Corporation | Apparatus and method for linear lesion ablation |
US6063077A (en) | 1996-04-08 | 2000-05-16 | Cardima, Inc. | Linear ablation device and assembly |
US5882346A (en) | 1996-07-15 | 1999-03-16 | Cardiac Pathways Corporation | Shapable catheter using exchangeable core and method of use |
US5855049A (en) * | 1996-10-28 | 1999-01-05 | Microsound Systems, Inc. | Method of producing an ultrasound transducer |
US5722403A (en) | 1996-10-28 | 1998-03-03 | Ep Technologies, Inc. | Systems and methods using a porous electrode for ablating and visualizing interior tissue regions |
US6024740A (en) | 1997-07-08 | 2000-02-15 | The Regents Of The University Of California | Circumferential ablation device assembly |
US5971983A (en) | 1997-05-09 | 1999-10-26 | The Regents Of The University Of California | Tissue ablation device and method of use |
US6012457A (en) | 1997-07-08 | 2000-01-11 | The Regents Of The University Of California | Device and method for forming a circumferential conduction block in a pulmonary vein |
US5938660A (en) | 1997-06-27 | 1999-08-17 | Daig Corporation | Process and device for the treatment of atrial arrhythmia |
US6117101A (en) | 1997-07-08 | 2000-09-12 | The Regents Of The University Of California | Circumferential ablation device assembly |
AU741167B2 (en) | 1997-07-08 | 2001-11-22 | Atrionix, Inc. | Circumferential ablation device assembly and method |
DE19814697C1 (en) | 1998-04-01 | 1999-10-21 | Doru Constantin Lupasco | Piezoelectric actuator, especially multilayer ceramic piezo-actuator used as positioning device, ultrasonic emitter, valve controller or sensor |
DE19942216C2 (en) * | 1999-09-03 | 2003-04-24 | Basf Drucksysteme Gmbh | Silicone rubber and iron-containing, inorganic solids and / or soot-containing recording material for the production of relief printing plates by means of laser engraving, process for the production of relief printing plates and the relief printing plate produced therewith |
AU5468301A (en) | 2000-03-15 | 2001-09-24 | Boston Scientific Limited | Ablation and imaging catheter |
USD454842S1 (en) * | 2000-06-30 | 2002-03-26 | Yazaki Corporation | Fuse |
WO2002010264A1 (en) * | 2000-07-28 | 2002-02-07 | The Penn State Research Foundation | A process for fabricating hollow electroactive devices |
JP2003179997A (en) * | 2001-12-13 | 2003-06-27 | Toshiba Corp | Manufacturing method of piezoelectric element and ultrasonic oscillator |
-
2003
- 2003-07-21 US US10/623,894 patent/US7247269B2/en not_active Expired - Lifetime
-
2004
- 2004-07-20 EP EP04778706A patent/EP1646309B1/en not_active Expired - Lifetime
- 2004-07-20 AT AT04778706T patent/ATE510489T1/en not_active IP Right Cessation
- 2004-07-20 WO PCT/US2004/023332 patent/WO2005009219A2/en active Application Filing
- 2004-07-20 JP JP2006521190A patent/JP4685013B2/en not_active Expired - Lifetime
- 2004-07-20 CA CA2533212A patent/CA2533212C/en not_active Expired - Fee Related
- 2004-07-20 AU AU2004258954A patent/AU2004258954A1/en not_active Abandoned
-
2009
- 2009-11-20 AU AU2009238347A patent/AU2009238347B2/en not_active Ceased
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4135109A (en) | 1977-09-09 | 1979-01-16 | Westinghouse Electric Corp. | High powered piezoelectric cylindrical transducer with threads cut into the wall |
Non-Patent Citations (2)
Title |
---|
FRAM: "Feasibility of RF Powered Thermal Balloon Ablation of Atrioventricular Bypass Tracts via the Coronary Sinus: In vivo Canine Studies", PACE, vol. 18, 1995, pages 1518 - 1530 |
HAISSAGUERRE ET AL., JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, vol. 7, no. 12, 1996, pages 1132 - 1144 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10076384B2 (en) | 2013-03-08 | 2018-09-18 | Symple Surgical, Inc. | Balloon catheter apparatus with microwave emitter |
Also Published As
Publication number | Publication date |
---|---|
EP1646309B1 (en) | 2011-05-25 |
EP1646309A2 (en) | 2006-04-19 |
ATE510489T1 (en) | 2011-06-15 |
JP2006528888A (en) | 2006-12-28 |
AU2009238347B2 (en) | 2012-05-24 |
JP4685013B2 (en) | 2011-05-18 |
EP1646309A4 (en) | 2008-10-15 |
US20050015953A1 (en) | 2005-01-27 |
US7247269B2 (en) | 2007-07-24 |
AU2004258954A1 (en) | 2005-02-03 |
WO2005009219A3 (en) | 2005-09-09 |
AU2009238347A1 (en) | 2009-12-17 |
CA2533212C (en) | 2011-11-08 |
CA2533212A1 (en) | 2005-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2533212C (en) | Method for making a spiral array ultrasound transducer | |
AU2004258943B2 (en) | Ablation device with spiral array ultrasound transducer | |
AU2005310276B2 (en) | Ablation device with phased array ultrasound transducer | |
JP2006528888A5 (en) | ||
US6607502B1 (en) | Apparatus and method incorporating an ultrasound transducer onto a delivery member | |
US6599288B2 (en) | Apparatus and method incorporating an ultrasound transducer onto a delivery member | |
US7655005B2 (en) | Circumferential ablation device assembly with dual expandable members | |
CA2552198A1 (en) | Circumferential ablation device assembly with an expandable member | |
EP1769759B1 (en) | Apparatus for ultrasound ablation | |
MXPA06000858A (en) | Ablation device with spiral array ultrasound transducer | |
MXPA06000857A (en) | Method for making a spiral array ultrasound transducer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004258954 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004778706 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2533212 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006521190 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2006/000857 Country of ref document: MX |
|
ENP | Entry into the national phase |
Ref document number: 2004258954 Country of ref document: AU Date of ref document: 20040720 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2004258954 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2004778706 Country of ref document: EP |